C

Crinetics Pharmaceuticals
D

CRNX

40.620
USD
-0.03
(-0.08%)
مفتوح الان
حجم التداول
18,387
الربح لكل سهم
-5
العائد الربحي
-
P/E
-9
حجم السوق
4,185,558,427
أصول ذات صلة المقالات

العنوان: Crinetics Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.